NRIX
NURIX THERAPEUTC-RG (NRIX)
NASDAQ
$23.01-$0.34 (-1.44%)
Price as of Oct 02, 2026 4:42 PM EDT
  • $2.4B
    Market Cap
  • 157.05%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
BLACKROCK, INC.
8.45%
8.8M
-155,293 (-1.77%)
Jun 30, 2026
VESTAL POINT CAPITAL, LP
7.76%
8.1M
+1.6M (+19.25%)
Jun 30, 2026
DEEP TRACK CAPITAL, LP
7.45%
7.7M
+1.4M (+17.98%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
7.40%
7.7M
+494,137 (+6.44%)
Dec 31, 2024
RUBRIC CAPITAL MANAGEMENT LP
6.96%
7.2M
+4.8M (+65.77%)
Jun 30, 2026
BLACKROCK INC.
6.57%
6.8M
+2.2M (+32.84%)
Jun 30, 2024
SVENNILSON PETER
6.51%
6.8M
+6.8M (+100.00%)
Sep 30, 2020

Current Ownership Distribution

  • Institutions1.3B (80.38%)
  • Mutual Funds305.7M (19.12%)
  • Insiders8.0M (0.50%)
  • Other0 (0.00%)

Insider Transactions

  • 0.50% (8.0M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 3
    Number of InsiderSelling (last 12 months)
  • $29.9M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Hansen Gwenn
Chief Scientific Officer
Exempt
Sep 01, 2026
$0.00
1,452
$0.00
60,858
Hansen Gwenn
Chief Scientific Officer
Exempt
Sep 01, 2026
$2,700.72
1,452
$1.86
118,679
Hansen Gwenn
Chief Scientific Officer
Sell
Sep 01, 2026
$36,982.44
1,452
$25.47
117,227
Hansen Gwenn
Chief Scientific Officer
Exempt
Aug 05, 2026
$0.00
4,356
$0.00
62,310
Hansen Gwenn
Chief Scientific Officer
Exempt
Aug 05, 2026
$8,102.16
4,356
$1.86
121,583
Hansen Gwenn
Chief Scientific Officer
Sell
Aug 05, 2026
$108,900.00
4,356
$25.00
117,227
Hansen Gwenn
Chief Scientific Officer
Sell
Aug 04, 2026
$35,802.60
1,500
$23.87
119,838
van Houte Hans
Chief Financial Officer
Sell
Aug 04, 2026
$42,860.63
1,794
$23.89
43,133
Hansen Gwenn
Chief Scientific Officer
Sell
Aug 04, 2026
$64,338.96
2,611
$24.64
117,227
van Houte Hans
Chief Financial Officer
Sell
Aug 04, 2026
$73,128.84
2,967
$24.65
40,166
Ring Christine
Chief Legal Officer
Exempt
Aug 03, 2026
$0.00
5,787
$0.00
122,824
Ring Christine
Chief Legal Officer
Exempt
Aug 03, 2026
$50,462.64
5,787
$8.72
25,699
Ring Christine
Chief Legal Officer
Sell
Aug 03, 2026
$382,358.20
16,589
$23.05
9,110
van Houte Hans
Chief Financial Officer
Exempt
Jul 30, 2026
$0.00
3,750
$0.00
11,250
Hansen Gwenn
Chief Scientific Officer
Exempt
Jul 30, 2026
$0.00
3,750
$0.00
11,250
Ring Christine
Chief Legal Officer
Exempt
Jul 30, 2026
$0.00
3,750
$0.00
11,250
Hansen Gwenn
Chief Scientific Officer
Exempt
Jul 30, 2026
$0.00
2,858
$0.00
20,009
van Houte Hans
Chief Financial Officer
Exempt
Jul 30, 2026
$0.00
2,858
$0.00
20,009
Hansen Gwenn
Chief Scientific Officer
Exempt
Jul 30, 2026
$0.00
3,572
$0.00
39,303
Ring Christine
Chief Legal Officer
Exempt
Jul 30, 2026
$0.00
2,858
$0.00
20,009
Hansen Gwenn
Chief Scientific Officer
Exempt
Jul 30, 2026
$0.00
3,750
$0.00
118,755
van Houte Hans
Chief Financial Officer
Exempt
Jul 30, 2026
$0.00
3,572
$0.00
39,303
Hansen Gwenn
Chief Scientific Officer
Exempt
Jul 30, 2026
$0.00
2,858
$0.00
121,613
Ring Christine
Chief Legal Officer
Exempt
Jul 30, 2026
$0.00
3,572
$0.00
39,303
Hansen Gwenn
Chief Scientific Officer
Exempt
Jul 30, 2026
$0.00
3,572
$0.00
125,185
van Houte Hans
Chief Financial Officer
Exempt
Jul 30, 2026
$0.00
3,750
$0.00
41,342
Hansen Gwenn
Chief Scientific Officer
Sell
Jul 30, 2026
$89,953.63
3,847
$23.38
121,338
Ring Christine
Chief Legal Officer
Exempt
Jul 30, 2026
$0.00
3,750
$0.00
17,329
van Houte Hans
Chief Financial Officer
Exempt
Jul 30, 2026
$0.00
2,858
$0.00
44,200
Ring Christine
Chief Legal Officer
Exempt
Jul 30, 2026
$0.00
2,858
$0.00
20,187